Legend Biotech (LEGN) Total Non-Current Liabilities: 2019-2025
Historic Total Non-Current Liabilities for Legend Biotech (LEGN) over the last 6 years, with Sep 2025 value amounting to $268.1 million.
- Legend Biotech's Total Non-Current Liabilities fell 23.14% to $268.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $268.1 million, marking a year-over-year decrease of 23.14%. This contributed to the annual value of $352.0 million for FY2024, which is 7.58% down from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Total Non-Current Liabilities is $268.1 million, which was down 31.06% from $388.9 million recorded in Q2 2025.
- Legend Biotech's Total Non-Current Liabilities' 5-year high stood at $388.9 million during Q2 2025, with a 5-year trough of $122,000 in Q3 2022.
- Over the past 3 years, Legend Biotech's median Total Non-Current Liabilities value was $348.8 million (recorded in 2024), while the average stood at $343.0 million.
- Per our database at Business Quant, Legend Biotech's Total Non-Current Liabilities crashed by 99.96% in 2022 and then skyrocketed by 265,863.93% in 2023.
- Legend Biotech's Total Non-Current Liabilities (Quarterly) stood at $124.3 million in 2021, then skyrocketed by 132.36% to $288.9 million in 2022, then soared by 31.83% to $380.8 million in 2023, then dropped by 7.58% to $352.0 million in 2024, then decreased by 23.14% to $268.1 million in 2025.
- Its last three reported values are $268.1 million in Q3 2025, $388.9 million for Q2 2025, and $363.5 million during Q1 2025.